Basit öğe kaydını göster

dc.contributor.authorKorkmaz, Taha Sukru
dc.contributor.authorKemerdere, Rahsan
dc.contributor.authorKayhan, Ahmet
dc.contributor.authorTanriverdi, Taner
dc.contributor.authorBaran, Oguz
dc.date.accessioned2021-03-06T10:33:27Z
dc.date.available2021-03-06T10:33:27Z
dc.date.issued2019
dc.identifier.citationBaran O., Kemerdere R., Korkmaz T. S. , Kayhan A., Tanriverdi T., "Can preoperative neutrophil to lymphocyte, lymphocyte to monocyte, or platelet to lymphocyte ratios differentiate glioblastoma from brain metastasis?", MEDICINE, cilt.98, 2019
dc.identifier.issn0025-7974
dc.identifier.otherav_eae63650-55c8-4160-8b45-4a77ffc85e77
dc.identifier.othervv_1032021
dc.identifier.urihttp://hdl.handle.net/20.500.12627/154291
dc.identifier.urihttps://doi.org/10.1097/md.0000000000018306
dc.description.abstractThis retrospective analysis of patients aims to show the blood levels of preoperative inflammatory markers in patients with glioblastoma and brain metastasis and to provide the diagnostic accuracy of the neutrophil-lymphocyte (NLR), lymphocyte-monocyte (LMR), and platelet-lymphocyte (PLR) ratios between the 2 groups of patients.
dc.language.isoeng
dc.subjectKlinik Tıp
dc.subjectTemel Tıp Bilimleri
dc.subjectSağlık Bilimleri
dc.subjectTıp
dc.subjectKlinik Tıp (MED)
dc.subjectTIP, GENEL & İÇECEK
dc.titleCan preoperative neutrophil to lymphocyte, lymphocyte to monocyte, or platelet to lymphocyte ratios differentiate glioblastoma from brain metastasis?
dc.typeMakale
dc.relation.journalMEDICINE
dc.contributor.departmentIstanbul Haseki Training & Research Hospital , ,
dc.identifier.volume98
dc.identifier.issue50
dc.contributor.firstauthorID271208


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster